TNF Pharmaceuticals Rebrands to Q/C Technologies
TNF Pharmaceuticals has rebranded to Q/C Technologies as of September 22, 2025, reflecting its strategic shift towards quantum-class computing. The company’s stock now trades under the ticker symbol ‘QCLS’ on the Nasdaq. This change aligns with its focus on photonic computing and exclusive rights to LightSolver’s platform, enhancing its market position. Q/C Technologies operates in high-performance computing, particularly in quantum-class cryptocurrency applications, with a current market cap of $9.29M and an average trading volume of 1,611,301.
TNF Pharmaceuticals ( (TNFA) ) just unveiled an update.
On September 22, 2025, TNF Pharmaceuticals officially changed its name to Q/C Technologies, reflecting its strategic shift towards quantum-class computing. The company’s stock began trading under the new ticker symbol ‘QCLS’ on the Nasdaq Stock Market on September 25, 2025. This transition aligns with Q/C Technologies’ focus on photonic computing and its exclusive rights to LightSolver’s platform, aiming to enhance its market position and shareholder value.
More about TNF Pharmaceuticals
Q/C Technologies, formerly known as TNF Pharmaceuticals, operates in the high-performance computing industry with a focus on quantum-class computing. The company holds exclusive global rights to LightSolver’s light-speed laser processing unit, which is used for quantum-class cryptocurrency applications, positioning it at the forefront of this innovative computing paradigm.
Average Trading Volume: 1,611,301
Technical Sentiment Signal: Strong Sell
Current Market Cap: $9.29M
